Overexpression of Annexin A2 Is Associated with Abnormal Ubiquitination in Breast Cancer
暂无分享,去创建一个
Zhengwei Yang | Shishan Deng | Baoqian Jing | Tianyong Xing | Lingmi Hou | Lingmi Hou | Shishan Deng | Zhengwei Yang | T. Xing | B. Jing
[1] Y. Shaul,et al. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. , 2005, Genes & development.
[2] Satoshi Inoue,et al. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. , 2002, Nature.
[3] A. Maitra,et al. Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer , 2011, PloS one.
[4] PhD Atsushi Kato MD,et al. Annexin II Overexpression Predicts Rapid Recurrence after Surgery in Pancreatic Cancer Patients Undergoing Gemcitabine-Adjuvant Chemotherapy , 2008, Annals of Surgical Oncology.
[5] L. Aravind,et al. Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26S Proteasome , 2002, Science.
[6] Satoshi Inoue,et al. Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.
[7] Lei Zhang,et al. Increased expression of Annexin A2 in oral squamous cell carcinoma. , 2009, Archives of oral biology.
[8] Shishan Deng,et al. Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics , 2007, Breast Cancer Research and Treatment.
[9] B. Sarcevic,et al. Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes , 2012, IUBMB life.
[10] Y. Yang,et al. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells. , 2009, Journal of proteome research.
[11] M. Petroski,et al. The ubiquitin system, disease, and drug discovery , 2008, BMC Biochemistry.
[12] F. Hirata,et al. Ubiquitination and SUMOylation of annexin A1 and helicase activity. , 2010, Biochimica et biophysica acta.
[13] H. Xiong,et al. Endothelial Cell Annexin A2 Regulates Polyubiquitination and Degradation of Its Binding Partner S100A10/p11* , 2008, Journal of Biological Chemistry.
[14] R. Layfield,et al. Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. , 2009, European journal of cancer.
[15] Li Chen,et al. Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue. , 2005, Cancer research.
[16] E. Morel,et al. The p11/S100A10 Light Chain of Annexin A2 Is Dispensable for Annexin A2 Association to Endosomes and Functions in Endosomal Transport , 2007, PloS one.
[17] D. Skarecky,et al. Annexin A2 positively contributes to the malignant phenotype and secretion of IL‐6 in DU145 prostate cancer cells , 2009, International journal of cancer.
[18] D. Lane,et al. Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity , 2004, Cell.
[19] T. Lorca,et al. Multiple phosphorylation events control mitotic degradation of the muscle transcription factor Myf5 , 2005, BMC Biochemistry.
[20] H. Usuki,et al. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. , 2008, International journal of oncology.
[21] S. Cordwell,et al. Immunoproteomics To Examine Cystic Fibrosis Host Interactions with Extracellular Pseudomonas aeruginosa Proteins , 2008, Infection and Immunity.
[22] Zu-Wen Sun,et al. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast , 2002, Nature.
[23] C. Ricciardelli,et al. The Role of Annexin A2 in Tumorigenesis and Cancer Progression , 2011, Cancer Microenvironment.